The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

As Medicare turns 60, Medscape convened an expert panel to discuss the use of AI in medicine, physician reimbursement, and ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

Influencers on social media tout the benefits of okra-infused water for glucose control. But experts are skeptical — at best.

As Medicare turns 60, Medscape convened an expert panel to discuss if physicians can survive without the program and the ways ...

This is especially true for older adults with type 2 diabetes (T2D) taking insulin and/or sulfonylureas — steadfast older ...

Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...

Biomarker panel based on capsule Cytosponge could simplify Barrett esophagus surveillance and reduce endoscopies in low-risk ...

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on ...

Nursing course applications in the UK have fallen 30% since 2021, prompting urgent calls for action to prevent further NHS ...